Understanding the Market | SENSETIME-W rose over 4% during trading, and its subsidiary SenseTime Medical recently announced the completion of Pre-A round financing

Zhitong
2025.02.21 02:51
portai
I'm PortAI, I can summarize articles.

SENSETIME-W's stock price rose more than 4% during intraday trading, with an increase of 3.47% as of the time of publication, priced at HKD 1.78, with a transaction volume of HKD 633 million. SENSETIME Medical recently announced the completion of its Pre-A round of financing, raising over 100 million yuan, led jointly by Yingfeng Holdings and an investment platform under the People's Medical Publishing House. This financing will be used to promote the research and commercialization of medical large models and smart hospital solutions. Minsheng Securities pointed out that the influx of quality funds into the AI + medical sector demonstrates the potential for the development of artificial intelligence in the healthcare industry

According to Zhitong Finance APP, SENSETIME-W (00020) rose over 4% during the trading session, and as of the time of writing, it has increased by 3.47%, priced at HKD 1.78, with a transaction volume of HKD 633 million.

In terms of news, recently, SenseTime announced that its subsidiary SenseTime Medical has completed its first round of financing exceeding 100 million yuan. This round was co-led by Yingfeng Holdings and the investment platform Renwei Technology Development Company under the People's Medical Publishing House, with multiple investment institutions participating. This financing will be used to promote the research and implementation of its medical large model "Da Yi" and the "SenseCare Smart Hospital" comprehensive solution, as well as to continue solidifying commercial cooperation. Minsheng Securities pointed out that high-quality funds are flowing significantly towards the "AI + healthcare" direction, and the rapid development of technology is continuously changing the industry's thinking patterns and concepts regarding health management. The AI-driven development of the healthcare industry is an inevitable trend, and many large technology companies both domestically and internationally are placing great importance on and continuously investing in technological research and development, indicating significant potential for future industry growth.

It is understood that SenseTime Medical was spun off from SenseTime and has developed for over 7 years. After confirming its entry into the healthcare field in 2018, SenseTime quickly established its research and development and product capabilities, forming a smart health team. Relying on SenseTime's supercomputing center, "SenseTime Medical" has built a large language model for the healthcare industry, "Da Yi," as well as a matrix of AI medical multimodal large models, promoting the intelligent transformation of the healthcare industry. The "SenseCare Smart Hospital" comprehensive solution was first launched by SenseTime in 2020 and has been updated and iterated, now creating platform products that include smart diagnosis and treatment platforms, smart medical service platforms, smart medical research platforms, and smart healthcare cloud platforms

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.